President Trump Withdraws Heidi Overton's FDA Nomination
President Donald Trump has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration (FDA) ahead of a critical Senate committee vote. The decision follows concerns regarding her ability to secure enough Republican support in Congress, particularly after recent midterm election losses left the GOP with slim margins in both chambers. Overton's candidacy faced significant opposition from medical groups and lawmakers due to her stances on childhood vaccinations, abortion medication (mifepristone), and flavored vaping products. The White House is reportedly considering Senator Roger Marshall of Kansas as a potential replacement nominee to lead the agency, which has recently seen a loss of over 4,500 staff members.

Topics: Drug pricing policy FDA nomination withdrawal GLP-1 medications Political appointments
Part of the story Trump Administration Officials Weigh Reconsidering FDA Commissioner Nominee Heidi Overton (3 articles)